News Headlines Article

F.D.A. Panel Backs Pre-Surgery Drug for Breast Cancer
New York Times

A federal advisory committee cleared the way on Thursday for the first approval of a cancer drug that would be used to treat patients before surgery to remove their tumors.

The advisory committee to the Food and Drug Administration voted 13 to 0, with one abstention, that Perjeta, a Genentech drug approved last year for late-stage breast cancer, could also be used at the disease’s earliest stage.